HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of metastatic liver tumor of colorectal cancer responding to low-dose CPT-11 chemotherapy].

Abstract
We report a case in which low-dose CPT-11 chemotherapy was effective for metastatic liver tumor of sigmoid colon cancer. A 49-year-old male with metastatic liver tumor, who had undergone sigmoidectomy with D2 lymphadenectomy, was treated by low-dose CPT-11 chemotherapy (CPT-11 30 mg/m2 x 3 days, every 2 weeks). After 7 courses of this chemotherapy, CT and ultrasound examinations showed a reduction of tumor size in the liver. This chemotherapy also showed no high grade toxicities. Therefore, low-dose CPT-11 chemotherapy seems to be effective for metastatic colorectal cancer, and safe in view of toxicities.
AuthorsKimihiko Funahashi, Toshitsugu Miki, Junichi Koike, Naohiro Washizawa, Yumiko Shibata, Hiroshi Matsumoto, Takayuki Tokuyama, Masamine Ryu, Hiroyuki Shiokawa, Tomohiko Goto, Tatsuo Teramoto
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 30 Issue 3 Pg. 419-21 (Mar 2003) ISSN: 0385-0684 [Print] Japan
PMID12669404 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Irinotecan
  • Camptothecin
Topics
  • Adenocarcinoma (drug therapy, secondary)
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Camptothecin (administration & dosage, analogs & derivatives)
  • Colorectal Neoplasms (drug therapy, secondary)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Irinotecan
  • Liver Neoplasms (drug therapy, secondary)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: